Key facts
- This page summarizes Neil Lerner's Form 4 filing for Compass Therapeutics, Inc. (CMPX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 25 Sep 2026, 08:01.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
Additional SEC filing notes
Footnote F1
62,500 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.